Your browser doesn't support javascript.
loading
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes.
Van Rampelbergh, Jean; Achenbach, Peter; Leslie, Richard David; Ali, Mohammad Alhadj; Dayan, Colin; Keymeulen, Bart; Owen, Katharine R; Kindermans, Martin; Parmentier, Frédéric; Carlier, Vincent; Ahangarani, Roxana R; Gebruers, Evelien; Bovy, Nicolas; Vanderelst, Luc; Van Mechelen, Marcelle; Vandepapelière, Pierre; Boitard, Christian.
Affiliation
  • Van Rampelbergh J; Imcyse S.A., Avenue Pré-Aily 14, Angleur, 4031, Liège, Belgium. j.vanrampelbergh@imcyse.com.
  • Achenbach P; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Leslie RD; Forschergruppe Diabetes, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany.
  • Ali MA; Department of Immunobiology, Queen Mary University of London, London, UK.
  • Dayan C; Diabetes Research Group, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
  • Keymeulen B; Diabetes Research Group, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
  • Owen KR; Member of Belgian Diabetes Registry, Academic Hospital and Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.
  • Kindermans M; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
  • Parmentier F; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK.
  • Carlier V; Ariana Pharmaceuticals SA, Paris, France.
  • Ahangarani RR; Ariana Pharmaceuticals SA, Paris, France.
  • Gebruers E; Imcyse S.A., Avenue Pré-Aily 14, Angleur, 4031, Liège, Belgium.
  • Bovy N; Imcyse S.A., Avenue Pré-Aily 14, Angleur, 4031, Liège, Belgium.
  • Vanderelst L; Imcyse S.A., Avenue Pré-Aily 14, Angleur, 4031, Liège, Belgium.
  • Van Mechelen M; Imcyse S.A., Avenue Pré-Aily 14, Angleur, 4031, Liège, Belgium.
  • Vandepapelière P; Imcyse S.A., Avenue Pré-Aily 14, Angleur, 4031, Liège, Belgium.
  • Boitard C; Imcyse S.A., Avenue Pré-Aily 14, Angleur, 4031, Liège, Belgium.
BMC Med ; 21(1): 190, 2023 05 24.
Article de En | MEDLINE | ID: mdl-37226224

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 1 Type d'étude: Clinical_trials Limites: Adult / Humans Langue: En Journal: BMC Med Sujet du journal: MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 1 Type d'étude: Clinical_trials Limites: Adult / Humans Langue: En Journal: BMC Med Sujet du journal: MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni